• LLY-507: SMYD2 Inhibitor Empowering Cancer & Fibrosis Assays

  2026-06-17

  LLY507, a potent and selective SMYD2 inhibitor from APExBIO, enables high-resolution dissection of lysine methylation in cancer and renal fibrosis research. Its nanomolar potency, cell activity, and robust selectivity streamline workflows in oncology and chronic disease models, minimizing off-target effects and experimental noise.

• PDI Inhibition Enhances Panobinostat Efficacy in Multiple My

  2026-06-17

  This study demonstrates that combining the protein disulfide isomerase (PDI) inhibitor LTI6426 with low-dose panobinostat significantly enhances anti-myeloma activity in preclinical models, even in proteasome inhibitor-resistant multiple myeloma. The findings highlight mechanistic synergy via ER stress modulation and suggest new directions for optimizing epigenetic and proteasome-targeted therapies.

• Gap26 and the Future of Connexin 43-Targeted Translational R

  2026-06-16

  This thought-leadership article explores how Gap26, a connexin 43 mimetic peptide, is redefining the study of gap junction biology and calcium signaling. By weaving mechanistic insights with strategic protocol guidance, it empowers translational researchers to unlock the full potential of intercellular communication modulation in neurobiology, cardiovascular science, and beyond. Drawing on the latest peer-reviewed evidence, including robust animal models of breakthrough cancer pain, the article situates Gap26 at the forefront of experimental innovation and translational opportunity.

• Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo

  2026-06-16

  Vacuolin-1 enables unrivaled specificity for dissecting lysosomal exocytosis, as shown by its pivotal role in disease models and membrane repair research. This article delivers actionable workflows, advanced troubleshooting, and strategic experimental guidance for maximizing the impact of Vacuolin-1 in cell biology.

• Moxifloxacin: Mechanistic Insights for Translational Innovat

  2026-06-15

  This thought-leadership article explores the dual roles of Moxifloxacin as both a broad-spectrum fluoroquinolone antibiotic and a strategic research tool for translational scientists. Drawing on recent mechanistic advances in DNA gyrase inhibition and leveraging validated protocol data, the article bridges fundamental molecular actions with actionable experimental guidance. By situating APExBIO’s Moxifloxacin within the evolving landscape of antibiotic toxicity and metabolic response research, it provides a competitive and visionary outlook for researchers aiming to optimize model selection, reproducibility, and translational relevance.

• GW 6471: Applied PPARα Antagonist Workflows in Lipidomics

  2026-06-15

  GW 6471 elevates PPARα antagonist research by enabling precise, reproducible modulation of lipid metabolism and hepatotoxicity pathways. This guide details actionable workflows, troubleshooting strategies, and the translational value of GW 6471, referencing cutting-edge studies and APExBIO’s quality standards.

• HyperScript RT SuperMix for qPCR: Precision cDNA Synthesis T

  2026-06-14

  HyperScript RT SuperMix for qPCR enables robust reverse transcription even from RNA templates with complex secondary structures and low concentrations. The SuperMix delivers high reproducibility and compatibility with multiple qPCR detection chemistries, supporting rigorous gene expression analysis. APExBIO's engineered M-MLV enzyme enhances thermal stability, ensuring authentic cDNA synthesis for two-step qRT-PCR workflows.

• Pregnenolone Carbonitrile in Translational Hepatic Disease M

  2026-06-13

  Discover how Pregnenolone Carbonitrile empowers advanced research in xenobiotic metabolism and liver fibrosis, integrating mechanistic, pharmacokinetic, and antifibrotic insights to guide strategic translational study design.

• Quercetin Alleviates Cataract via Hippo Pathway Modulation

  2026-06-12

  This study demonstrates that quercetin reduces cataract formation by suppressing the Hippo signaling pathway, thereby promoting lens epithelial cell survival and mitigating oxidative stress. The findings clarify the molecular mechanisms behind quercetin’s protective effects and highlight the Hippo pathway as a potential target for non-surgical cataract therapies.

• Digoxin (SKU B7684): Reliable Solutions for Cardiac and Anti

  2026-06-12

  This article addresses real laboratory challenges in cell viability, cardiac contractility, and antiviral research, demonstrating how Digoxin (SKU B7684) supports reproducible and interpretable outcomes. By leveraging scenario-based questions, the piece connects bench-level needs to evidence-backed protocols and vendor selection, highlighting the advantages of APExBIO’s high-purity Digoxin.

• Olive Biophenols Mitigate Alzheimer’s Pathology In Vitro and

  2026-06-11

  This study demonstrates that olive-derived biophenols, notably oleuropein, verbascoside, and rutin, significantly reduce amyloid beta aggregation and neurotoxicity in cellular and mouse models of Alzheimer’s disease. These findings highlight the therapeutic potential of natural polyphenols for modifying disease progression and point to new avenues for translational neurodegeneration research.

• Peripheral Endosome Entrapment Limits LNP Cargo Release Effi

  2026-06-11

  This study reveals that lipid nanoparticles (LNPs) trapped in peripheral endosomes, rather than lysosomes, are a critical bottleneck for efficient intracellular delivery and endosomal escape. The findings highlight the importance of fine-tuning endolysosomal activity and trafficking to optimize RNA-based therapeutic delivery, with implications for advanced RNA labeling and probe synthesis workflows.

• p-Cresyl Sulfate: Applied Workflows for Endothelial Dysfunct

  2026-06-10

  p-Cresyl sulfate (p-tolyl hydrogen sulfate) is transforming vascular complication studies and biomarker development in chronic kidney disease research. Leveraging APExBIO's high-purity reagent and recent mechanistic breakthroughs, researchers can refine in vitro and in vivo models of endothelial dysfunction with enhanced reproducibility and mechanistic clarity.

• Fluorescein Tyramide: Unveiling Ultra-High Sensitivity in Ne

  2026-06-10

  Discover how Fluorescein Tyramide, a premier fluorescent labeling dye, is revolutionizing ultra-sensitive detection in neural circuit and behavioral research. This in-depth article uniquely explores advanced assay design, protocol nuances, and translational insights from recent oxytocin signaling studies.

• iRhom2 Regulates Olfactory Receptor Adaptation in Mice

  2026-06-09

  This study reveals a novel, neuron-specific role for iRhom2 in the regulation of olfactory receptor (OR) gene expression and activity-dependent adaptation in mouse olfactory sensory neurons. The findings highlight iRhom2 as a molecular link between odor stimulation and dynamic OR repertoire modulation, with implications for sensory biology and molecular genetics.

446 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page